Lal Bansi, Gund Vitthal Genbhau, Gangopadhyay Ashok Kumar, Nadkarni S R, Dikshit Vidula, Chatterjee D K, Shirvaikar R
Department of Medicinal Chemistry, Quest Institute of LifeSciences, Nicholas Piramal India Limited, Mulund (w) Mumbai 4000 80, India.
Bioorg Med Chem. 2003 Nov 17;11(23):5189-98. doi: 10.1016/j.bmc.2003.08.003.
Mulundocandin (1), is an echinocandin class of lipopeptide. It has wide spectrum of antifungal activity against Candida and Aspergillus species. Semisynthetic modification at Ornithine-5-hydroxyl (hemiaminal function) of 1 was carried out to improve solution stability and hence in vivo activity. Synthesis of ether (C-OR), thioether (C-SR) and C-N linkage at hemiaminal function have been described. All synthetic analogues were evaluated for their stability in aqueous solution and found to be more stable than mulundocandin. Antifungal activity of Orn-5 analogues was evaluated both in vitro against Candida albicans and Aspergillus fumigatus by agar well method and in vivo (oral and intraperitoneal) in C. albicans infected Swiss mice. Results of in vivo assays of analogues 2-9 by the oral route suggests that the introduction of either oxygen nucleophiles (-OR) or sulphur nucleophiles (-SR), at either Orn-5 or at both Orn-5 and HTyr-4 positions, results in retaining the activity of the parent compound with improved aqueous stability in most cases. Compound 9 has shown improved antifungal activity in comparison to mulundocandin by oral application in Swiss mice.
穆伦多坎丁(1)是一种棘白菌素类脂肽。它对念珠菌属和曲霉菌属具有广泛的抗真菌活性。对1的鸟氨酸-5-羟基(半缩醛胺官能团)进行半合成修饰,以提高溶液稳定性,从而提高体内活性。已描述了在半缩醛胺官能团处合成醚(C-OR)、硫醚(C-SR)和C-N键。对所有合成类似物在水溶液中的稳定性进行了评估,发现它们比穆伦多坎丁更稳定。通过琼脂孔法在体外对白色念珠菌和烟曲霉评估了鸟氨酸-5类似物的抗真菌活性,并在感染白色念珠菌的瑞士小鼠体内(口服和腹腔注射)进行了评估。通过口服途径对类似物2-9进行体内试验的结果表明,在鸟氨酸-5或鸟氨酸-5和高酪氨酸-4位置引入氧亲核试剂(-OR)或硫亲核试剂(-SR),在大多数情况下会保留母体化合物的活性,并提高其在水中的稳定性。与穆伦多坎丁相比,化合物9通过在瑞士小鼠中口服应用显示出更高的抗真菌活性。